FITCHBURG, Mass., March 2, 2015 (GLOBE NEWSWIRE) -- Micron Products, Inc. (Micron), a wholly-owned subsidiary of Arrhythmia Research Technology, Inc. (NYSE MKT:HRT), announced today it has appointed medical device industry professional Michael Collette as the Company's Vice President of Quality, effective February 16, 2015. Mr. Collette brings more than 25 years of extensive quality and regulatory experience to Micron, including a long career in medical device manufacturing. He has led quality systems for leading medical device manufacturers, including NxStage Medical, Cynosure, Vaupell Northeast Molding and Tooling, and Smiths Medical.
Mr. Collette was most recently an Executive Quality Management System Consultant for several major medical device companies, including Micron Products. Prior to consulting, Mike was the Vice President of Quality for NxStage Medical, where he was responsible for all Quality Engineering, Post Market Surveillance, and Supplier Quality activities. He also oversaw strategic second-sourcing of key manufacturing capabilities, both domestically and internationally.
"Mike's wealth of experience is an ideal fit for the direction in which we are taking Micron," said Salvatore Emma, Jr., President and CEO. "Micron is building its reputation as a world-class medical device contract manufacturer through innovative products and services by providing the highest quality and value for its OEM customers. Mike's leadership and experience will be integral to our strategy as we add new capabilities, attract new customers and offer the best quality and value to the medical device industry."
Mr. Collette stated, "I am excited to become a member of the Micron Products team and to contribute to the growth of Micron as a world-class medical device company. The Company is on the right path to succeed in the ever-changing and increasing complex medical device world. It is truly an honor to be part of the Micron family."
About Arrhythmia Research Technology, Inc.
Arrhythmia Research Technology, Inc., through its wholly-owned subsidiary, Micron Products, Inc., is a diversified contract manufacturing organization that produces highly-engineered, innovative medical device technologies requiring precision machining and injection molding. Micron also manufactures components, devices and equipment for military, law enforcement, industrial and automotive applications. The Company is also a market leader in the production and sale of silver/silver chloride coated and conductive resin sensors used as consumable component parts in the manufacture of integrated disposable electrophysiological sensors. The Company's strategy for growth is to build a best-in-class quality organization and capitalize on its engineering design expertise and reliable, proprietary manufacturing processes to further penetrate its position in the medical device contract manufacturing market.
The Company routinely posts news and other important information on its websites: http://www.arthrt.com and http://www.micronproducts.com .
Safe Harbor Statement
Forward-looking statements made herein are based on current expectations of Arrhythmia Research Technology, Inc. ("our" or the "Company") that involve a number of risks and uncertainties and should not be considered as guarantees of future performance. The factors that could cause actual results to differ materially include our ability to forecast future prospects, to retain customers who represent significant proportions of revenue; our ability to maintain our pricing model and/or decrease our cost of sales; our ability to increase sales of higher margin products and services; our ability to manage our level of debt and provisions in the debt agreements which could limit our ability to react to changes in the economy or our industry; failure to comply with financial and other covenants in our credit facility; volatility in commodity and energy prices and our ability to offset higher costs with price increases; continued availability of supplies or materials used in manufacturing at competitive prices; variability of customer delivery requirements; variations in the mix of products sold; a stable interest rate market and/or a stable currency rate environment in the world, and specifically the countries where we are doing business; amount and timing of investments in capital equipment, sales and marketing, engineering and information technology resources and our ability to offset higher costs with price increases. More information about factors that potentially could affect the Company's financial results is included in the Company's filings with the Securities and Exchange Commission.
For more information on Micron Products, Inc. or Arrhythmia Research Technology, Inc. contact: Investor and Media Contact: Deborah K. Pawlowski Kei Advisors LLC 716.843.3908 Company Contact: Derek T. Welch Chief Financial Officer 978.345.5000
